Holding(s) in Company
Updated : 17:28
Synairgen plc
("Synairgen" or the "Company")
Holding(s) in Company
Southampton, UK,: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it was informed on 21 August 2020 that Leonard Licht, a private investor, now holds 7,375,000 ordinary shares of 1 pence each in the capital of the Company, representing 4.93% of the Company's issued share capital.
Enquiries:
Synairgen plc | +44 (0) 23 8051 2800 |
Richard Marsden (Chief Executive Officer) | |
finnCap - nominated adviser and broker | +44 (0) 20 7220 0500 |
Geoff Nash, Kate Bannatyne, Charlie Beeson (Corporate Finance) | |
Consilium Strategic Communications - financial media and investor relations adviser | +44 (0) 20 3709 5700 |
Mary-Jane Elliott, Sue Stuart, Olivia Manser |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.